BioInvent Issues Statement Confirming that it does not Hold Cash Deposits or Securities at Silicon Valley Bank
LUND, SWEDEN / ACCESSWIRE / March 13, 2023 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer …
Weiterlesen »